
Allan Tsung MD
Hepatobiliary Surgery, Pancreas, Surgical Oncology (Other than Breast)
Chair, Professor, University of Virginia
Join to view full profile
1240 Lee StCharlottesville, VA 22908
Phone+1 434-924-2839
Fax+1 434-244-9437
Dr. Tsung is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Allan Tsung, MD is a tenured Professor and Chair of the Department of Surgery at the University of Virginia. His leadership focuses on advancing surgical care, strengthening institutional and system-wide impact, and mentoring the next generation of academic surgeons. He prioritizes faculty development, clinical integration across community and academic sites, and building sustainable research and educational infrastructure.
Dr. Tsung specializes in the surgical management of liver, bile duct, and pancreatic cancers, with expertise in minimally invasive and robotic approaches. He is widely recognized for his clinical work in hepatobiliary and pancreatic surgery and directs complex oncologic care through multidisciplinary programs.
As a surgeon-scientist, Dr. Tsung leads an NIH-funded research program focused on inflammation and its effects on the tumor microenvironment. His lab studies innate immunity in cancer using clinically relevant models and human cohort data. He also conducts clinical trials and health services research aimed at improving access, quality, and equity in surgical oncology. He has authored over 300 peer-reviewed publications and served as Principal Investigator on multiple NIH and foundation grants.
Under his leadership, UVA Surgery entered the top 20 nationally in NIH funding and expanded its programs across four hospitals. He also launched initiatives in robotic training, global surgery, and structured mentorship.
Nationally, Dr. Tsung is Vice President of the Society of Clinical Surgery. He previously served as President of the Society of University Surgeons and the Society of Asian Academic Surgeons, and has held leadership roles in the ACS, SSO, SSAT, AHPBA, and the ASA.
Education & Training
UPMC Medical Education (Pittsburgh)Residency, Surgery, 2000 - 2008
State University of New York Downstate Medical Center College of MedicineClass of 2000
Certifications & Licensure
VA State Medical License 2022 - 2028
OH State Medical License 2018 - 2023
PA State Medical License 2001 - 2018
American Board of Surgery Surgery
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory - Core EMR, Epic Systems Corporation, 2013-2017
- CMS Meaningful Use Stage 1 Certification dbMotion, dbMotion Inc., 2013-2017
- CMS Meaningful Use Stage 2 Certification MyUPMC, UPMC, 2013-2017
Clinical Trials
- Stereotactic Body Radiation Therapy (SBRT) for Liver Mets Start of enrollment: 2012 Mar 23
Publications & Presentations
PubMed
- Regulatory T cells in autoimmune liver diseases.Shuhan Chen, Hongji Zhang, Hai Huang, Allan Tsung, Han Wang
Gut. 2026-10-01 - Trends in New National Institutes of Health Awards to Surgeon-Scientists in 2025.Mackenzie M Mayhew, Kali Holsinger, Celine Jeun, Jordan Lu, Nidhi Kuchimanchi
JAMA Surgery. 2026-09-30 - Integrated single-cell multiomics reveals neutrophil-driven immune-metabolic reprogramming of Kupffer cells via thrombospondin-1/CD36 after surgical stress.Hongji Zhang, Xingping Huang, Preethi Jayakumar, Yunwei Zhang, Ti Yang
JCI Insight. 2026-09-22
Journal Articles
- Nonsuperiority of the Anterior Approach to Conventional Hepatectomy for Resection of Colorectal Liver MetastasisIswanto Sucandy, Allan Tsung, JAMA Surgery
- Changes in Performance of More Than 1000 Minimally Invasive Liver ResectionsForat Swaid, Iswanto Sucandy, Samer Tohme, Allan Tsung, David A Geller, JAMA Surgery
- Preoperative Biliary Drainage Is Associated with Increased Complications After Liver Resection for Proximal CholangiocarcinomaAllan Tsung, Rajesh Ramanathan, Samer Tohme, Journal of gastrointestinal surgery
Authored Content
- Changes in Performance of More Than 1000 Minimally Invasive Liver ResectionsAugust 2020
Press Mentions
Review Reveals Real-World Results of New, Incisionless Liver Cancer TreatmentSeptember 23rd, 2026
Early Histotripsy Use for Liver Tumors Raises Questions About Patient SelectionAugust 21st, 2026
Exercise & Nutrition Supplements Reduce Sarcopenia Risk Post-Liver ResectionSeptember 12th, 2025
Grant Support
- Postdoctoral Training Grant for MDs in Surgical Oncology ResearchUNIVERSITY OF VIRGINIA2011–2031
- Surgery triggered immune response and liver metastasesUNIVERSITY OF VIRGINIA2018–2028
- Organoid modeling of pre-metastatic niche formation in the liver by primary colorectal tumor secreted factorsOHIO STATE UNIVERSITY2022–2025
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: